$Xilio Therapeutics (XLO.US)$Gilead Sciences Acquires 7.85M Xilio Therapeutics Shares At $1.04 Each, Raising Ownership To Over 10%, Along With 6.1M Pre-Funded Warrants Capped At 19.99% Ownership
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more